The outcome and cost-effectiveness of nurse-led care in the community for people with rheumatoid arthritis: a non-randomised pragmatic study
- PMID: 26307614
- PMCID: PMC4550717
- DOI: 10.1136/bmjopen-2015-007696
The outcome and cost-effectiveness of nurse-led care in the community for people with rheumatoid arthritis: a non-randomised pragmatic study
Abstract
Objective: To determine the outcome and cost-effectiveness of nurse-led care in the community for people with rheumatoid arthritis (RA).
Design: Non-randomised pragmatic study.
Setting: Primary (7 primary care practices) and secondary care (single centre) in the UK.
Methods: In a single area, pragmatic non-randomised study, we assessed the outcome, cost-effectiveness of community-based nurse-led care (NLC) compared with rheumatologist-led outpatient care (RLC). Participants were 349 adults (70% female) with stable RA assessed at baseline, 6 and 12 months. In the community NLC arm there were 192 participants. Outcome was assessed using Stanford Health Assessment Questionnaire (HAQ). The economic evaluation (healthcare perspective) estimated cost relative to change in HAQ and quality-adjusted life years (QALY) derived from EQ-5D-3L. We report complete case and multiple imputation results from regression analyses.
Results: The demographics and baseline characteristics of patients in the community group were comparable to those under hospital care apart from use of biological disease-modifying antirheumatic drugs (DMARDS), which were adjusted for in the analysis. The mean incremental cost was estimated to be £224 less for RLC compared to the community NLC, with wide CIs (CI -£213 to £701, p=0.296). Levels of functional disability were not clinically significantly higher in the community NLC group: HAQ 0.096 (95% CI -0.026 to 0.206; p=0.169) and QALY 0.023 (95% CI -0.059 to 0.012; p=0.194).
Conclusions: The results suggest that community care may be associated with non-significant higher costs with no significant differences in clinical outcomes, and this suggests a low probability that it is cost-effective.
Keywords: HEALTH ECONOMICS; RHEUMATOLOGY.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Figures
Similar articles
-
The outcome and cost-effectiveness of nurse-led care in people with rheumatoid arthritis: a multicentre randomised controlled trial.Ann Rheum Dis. 2014 Nov;73(11):1975-82. doi: 10.1136/annrheumdis-2013-203403. Epub 2013 Aug 27. Ann Rheum Dis. 2014. PMID: 23982436 Free PMC article. Clinical Trial.
-
Shared care or nurse consultations as an alternative to rheumatologist follow-up for rheumatoid arthritis (RA) outpatients with stable low disease-activity RA: cost-effectiveness based on a 2-year randomized trial.Scand J Rheumatol. 2015;44(1):13-21. doi: 10.3109/03009742.2014.928945. Epub 2014 Nov 7. Scand J Rheumatol. 2015. PMID: 25380077 Clinical Trial.
-
The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis.Health Technol Assess. 2005 Sep;9(34):iii-iv, ix-x, 1-78. doi: 10.3310/hta9340. Health Technol Assess. 2005. PMID: 16153351 Clinical Trial.
-
Rituximab for the treatment of rheumatoid arthritis.Health Technol Assess. 2009 Sep;13 Suppl 2:23-9. doi: 10.3310/hta13suppl2/04. Health Technol Assess. 2009. PMID: 19804686 Review.
-
Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis.Health Technol Assess. 2010 Oct;14(Suppl. 2):1-10. doi: 10.3310/hta14suppl2/01. Health Technol Assess. 2010. PMID: 21047485 Review.
Cited by
-
The impact of introducing multidisciplinary care assessments on access to rheumatology care in British Columbia: an interrupted time series analysis.BMC Health Serv Res. 2022 Mar 11;22(1):327. doi: 10.1186/s12913-022-07715-x. BMC Health Serv Res. 2022. PMID: 35277162 Free PMC article.
-
Development of generic core competences of health professionals in rheumatology: a systematic literature review informing the 2018 EULAR recommendations.RMD Open. 2019 Oct 23;5(2):e001028. doi: 10.1136/rmdopen-2019-001028. eCollection 2019. RMD Open. 2019. PMID: 31749985 Free PMC article. Review.
-
Direct healthcare resource utilisation, health-related quality of life, and work productivity in patients with moderate rheumatoid arthritis: an observational study.BMC Musculoskelet Disord. 2021 Mar 13;22(1):277. doi: 10.1186/s12891-021-04110-1. BMC Musculoskelet Disord. 2021. PMID: 33714274 Free PMC article.
-
Patient Satisfaction and Costs of Multidisciplinary Models of Care in Rheumatology: a Review of the Recent Literature.Curr Rheumatol Rep. 2018 Mar 17;20(4):19. doi: 10.1007/s11926-018-0727-3. Curr Rheumatol Rep. 2018. PMID: 29550993 Review.
-
Nurses' roles in the management of chronic inflammatory arthritis: a systematic review.Rheumatol Int. 2018 Nov;38(11):2027-2036. doi: 10.1007/s00296-018-4135-9. Epub 2018 Aug 20. Rheumatol Int. 2018. PMID: 30128732 Free PMC article.
References
-
- Office NA. Services for people with rheumatoid arthritis 2009.
-
- 2004 Health D of. Improving Chronic Disease Management [Internet] http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/publication....
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical